Mesoblast Limited
MEOBF
$1.37
-$0.25-15.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 13.50% | 0.00% | -70.31% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -6.39% | 0.00% | -9.01% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -12.69% | 0.00% | 259.33% | 0.00% |
| Change in Net Operating Assets | 0.00% | -119.49% | 0.00% | 143.20% | 0.00% |
| Cash from Operations | 0.00% | 5.62% | 0.00% | 17.64% | 0.00% |
| Capital Expenditure | 0.00% | -37.66% | 0.00% | 60.31% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 977.94% | 0.00% | -35.85% | 0.00% |
| Cash from Investing | 0.00% | 7,066.67% | 0.00% | 89.77% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 68.54% | 0.00% | -430.40% | 0.00% |
| Issuance of Common Stock | 0.00% | -94.78% | 0.00% | -35.28% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 64.26% | 0.00% | 4.93% | 0.00% |
| Cash from Financing | 0.00% | -149.28% | 0.00% | -72.62% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 52.70% | 0.00% | -204.24% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -70.83% | 0.00% | -334.03% | 0.00% |
